Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $539M | $455M | $337M | $375M | $334M | $288M | $467M | $556M | $661M | $978M |
| Revenue growth | — | -15.5% | -25.9% | 11.2% | -10.9% | -13.9% | 62.3% | 18.9% | 18.9% | 48.0% |
| Operating income | $113M | -$69.1M | -$123M | $2.80M | -$63.6M | -$125M | $75.8M | $97.3M | $49.1M | $133M |
| Operating margin | 20.9% | -15.2% | -36.4% | 0.7% | -19.0% | -43.5% | 16.2% | 17.5% | 7.4% | 13.6% |
| Net income | $93.2M | -$101M | -$95.7M | $1.72M | -$30.8M | -$128M | $63.3M | $73.9M | $140M | $83.3M |
| Net margin | 17.3% | -22.1% | -28.4% | 0.5% | -9.2% | -44.6% | 13.5% | 13.3% | 21.2% | 8.5% |
| EPS (diluted) | $2.47 | -$2.69 | -$2.58 | $0.05 | -$0.87 | -$3.63 | $2.01 | $2.29 | $2.77 | $1.20 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $247M | $108M | $45.5M | $14.7M | -$21.1M | $38.4M | -$5.81M | $75.9M | $93.4M | $191M |
| Capital expenditures | $25.8M | $27.6M | $32.1M | $11.5M | $11.9M | $9.99M | $18.9M | $32.6M | — | — |
| Free cash flow | $221M | $80.4M | $13.4M | $3.18M | -$33.0M | $28.4M | -$24.7M | $43.2M | — | — |
| Share buybacks | $24.2M | $0.00 | $100M | $26.6M | $25.0M | $24.2M | $20.8M | $0.00 | — | — |
| Dividends paid | — | — | — | — | — | — | $0.00 | $0.00 | $75.0M | $0.00 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $423M | $493M | $418M | $399M | $346M | $355M | $265M | $7.41M | $73.3M | $203M |
| Total assets | $1.46B | $1.40B | $1.19B | $1.21B | $1.15B | $1.01B | $970M | $475M | $1.20B | $1.27B |
| Total liabilities | $105M | $105M | $96.3M | $116M | $110M | $113M | $97.6M | $146M | $239M | $211M |
| Long-term debt | — | — | — | — | — | — | — | — | $25.4M | — |
| Shareholders' equity | $1.36B | $1.29B | $1.10B | $1.09B | $1.04B | $181M | $251M | $329M | $958M | $1.06B |
| Retained earnings | $1.50B | $1.40B | $1.21B | $1.18B | $1.13B | $973M | $950M | $146M | $211M | $285M |
| Shares (wtd avg diluted) | 37.7M | 37.5M | 37.1M | 36.2M | 35.3M | 35.3M | 31.4M | 32.3M | 50.6M | 69.4M |
Every figure is extracted from Innovex International, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.